Wells Fargo & Company »

Phathom Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $99k 11k 9.13
2023-09-30 $75k 7.3k 10.37
2023-06-30 $137k 9.6k 14.32
2022-09-30 $5.0k 407 12.29
2022-06-30 $5.0k 599 8.35
2022-03-31 $22k 1.6k 13.71
2021-12-31 $173k 8.8k 19.63
2021-03-31 $132k 3.5k 37.43
2020-12-31 $375k 11k 33.22
2020-09-30 $316k 8.6k 36.63
2020-06-30 $379k 12k 32.94
2020-03-31 $163k 6.3k 25.88
2019-12-31 $27k 876 30.82